ARCHIVES

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

Pressure Grows On Upton To Reveal Plans

November 23, 1979

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997